Literature DB >> 3128590

The generation and cellular distribution of leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and glucan particles.

R Mahauthaman1, C J Howell, B W Spur, L J Youlten, T J Clark, M H Lessof, T H Lee.   

Abstract

Human eosinophils (EOSs) stimulated under optimal conditions with 5 X 10(8) unopsonized zymosan particles at 37 degrees C for 30 minutes produced an average total immunoreactive leukotriene (LT) C4 of 1.6 ng per 10(6) EOSs, and 30% to 60% of the generated product remained cell associated. The dose-response characteristics of zymosan-induced LTC4 generation were different from those of phagocytosis, suggesting that the two events were independent. Pretreatment of EOSs with 10(-8) mol/L of formyl-methionyl-leucyl-phenylalanine for 30 minutes led to a twofold to fivefold augmentation of LTC4 generation by cells subsequently activated by unopsonized zymosan. Optimal EOS activation with 1 mumol/L of the calcium ionophore A23187 at 37 degrees C for 15 minutes produced more than 100 times greater quantities of LTC4 than with zymosan. The amount of immunoreactive LTC4 that remained cell associated after calcium ionophore A23187 stimulation reached a maximum after 5 minutes and then declined. Of the relatively small amount generated in the first minute, 71% was cell associated, but this figure declined to 9% after 15 minutes, by which time there had been a redistribution of the LTC4 to the supernatant. Inflammatory leukocytes may respond to zymosan because the cells recognize either one or both of its major polysaccharide components, glucan and mannan. Glucan, but not mannan, stimulated EOSs to generate LTC4 in a dose- and time-dependent manner. Under optimal conditions, there was no significant difference in the total quantities of LTC4 elaborated by EOSs stimulated by glucan and by unopsonized zymosan. This suggests that zymosan may induce leukotriene generation in the human EOS through a glucan recognition mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128590     DOI: 10.1016/0091-6749(88)91041-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects.

Authors:  A P Sampson; R U Thomas; J F Costello; P J Piper
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 2.  Pattern-recognition receptors in human eosinophils.

Authors:  Anne Månsson Kvarnhammar; Lars Olaf Cardell
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

3.  Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions.

Authors:  A M Campbell; S T Harper; C Hallam; E Wells; J Mann; C Robinson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  Enzyme-linked immunosorbent assay specific for (1-->6) branched, (1-->3)-beta-D-glucan detection in environmental samples.

Authors:  D K Milton; K U Alwis; L Fisette; M Muilenberg
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

5.  Measurement of beta(1-->3)-glucans in occupational and home environments with an inhibition enzyme immunoassay.

Authors:  J Douwes; G Doekes; R Montijn; D Heederik; B Brunekreef
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

6.  Enhancement of human monocyte beta-glucan receptors by glucocorticoids.

Authors:  J Kay; J K Czop
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

7.  Human bronchial fibroblasts express the 5-lipoxygenase pathway.

Authors:  Anna J James; John F Penrose; Angelica M Cazaly; Stephen T Holgate; Anthony P Sampson
Journal:  Respir Res       Date:  2006-07-27

8.  Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes.

Authors:  J K Czop; J Kay
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

Review 9.  Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1.

Authors:  Sainkhuu Batbayar; Dong Hee Lee; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2012-09       Impact factor: 4.634

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.